Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection
Authors:
- 29 January 2026
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (19) , e05516
Abstract
Rejection following heart transplantation remains a significant challenge in the medical science. In addition to the immune response, the inflammatory response and microvascular endothelial damage can exacerbate rejection; however, current therapies focus primarily on the immune response. Numerous studies have confirmed that miR‐126 regulates vascular inflammation and promotes angiogenesis. To achieve the precise targeted delivery of miR‐126, macrophage biomimetic ultrasound phase‐change cationic nanoparticles carrying miR‐126 (miR‐126‐MCNPs) are synthesized. Incorporation of the macrophage membrane enhances the anti‐phagocytic and inflammatory targeting of nanoparticles, thereby prolonging the circulation time and promoting aggregation in the transplanted heart. Using ultrasound‐targeted microbubble destruction (UTMD), the perfluoropentane nanoparticle core undergoes a phase change in the ultrasound irradiation zone, allowing the targeted delivery of macrophage membranes and miR‐126, and significantly improving the transfection efficiency of the miR‐126. Consequently, anti‐inflammatory effects are achieved, such as inhibition of macrophage and CD3 + T cells infiltration, and alteration of M2‐type macrophage differentiation. In addition, this study demonstrates that the combination of miR‐126‐MCNPs with UTMD can alleviate the extent of vascular endothelial and interstitial fibrosis in transplanted hearts, increase angiogenesis, and improve microcirculation and cardiac function. This research provides a new strategy for the precision‐targeted therapy of cardiac transplant rejection.Keywords
Funding Information
- National Natural Science Foundation of China (U22A20346 82402283)
- China Postdoctoral Science Foundation (2024MD763970)
- Heilongjiang Provincial Postdoctoral Science Foundation (LBHZ23229)
- Heilongjiang Provincial Postdoctoral Science Foundation (LBHZ23237)
This publication has 41 references indexed in Scilit:
- Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative StressAdvanced Materials, 2024
- Bio‐Responsive Sliver Peroxide‐Nanocarrier Serves as Broad‐Spectrum Metallo‐β‐lactamase Inhibitor for Combating Severe PneumoniaAdvanced Materials, 2023
- Aggregation‐Induced Emission‐Based Macrophage‐Like Nanoparticles for Targeted Photothermal Therapy and Virus Transmission Blockage in MonkeypoxAdvanced Materials, 2023
- Lipid Nanoparticles Optimized for Targeting and Release of Nucleic AcidAdvanced Materials, 2023
- Recent Advances of Seed‐Mediated Growth of Metal Nanoparticles: from Growth to ApplicationsAdvanced Materials, 2023
- Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer ImmunotherapyAdvanced Materials, 2023
- Optimizing Lipid Nanoparticles for Delivery in PrimatesAdvanced Materials, 2023
- Unraveling the Plasma Protein Corona by Ultrasonic Cavitation Augments Active‐Transporting of Liposome in Solid TumorAdvanced Materials, 2023
- Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow HomingAdvanced Materials, 2021
- Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor ActivityAdvanced Materials, 2019